Global Alcohol Addiction Therapeutics Market By Type (5-Ht3 Receptor Antagonist, Antidotes, And Others), By End User (Hospital Pharmacies, Retail Pharmacies, Rehabilitation Centers, And Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019-2029

Market.us announces publication of its most recently generated research report titled, “Global Alcohol Addiction Therapeutics Market by Type (5-HT3 Receptor Antagonist, Antidotes, and Others), by End User (Hospital Pharmacies, Retail Pharmacies, Rehabilitation Centers, and Others), and by Region – Global Forecast to 2029.”, which offers a holistic view of the global alcohol addiction therapeutics market through systematic segmentation that covers every aspect of the target market.

The global alcohol addiction therapeutics market is projected to be US$ 837.6 Mn in 2019 to reach US$ 1,498.3 Mn by 2029 at a CAGR of 6.0%.

Alcohol addiction therapeutics are used to treat the cognitive and psychological aspects of alcohol addiction. These type of therapeutics offers various treatments such as medical, meditation, homeopathic, and rehabilitation center. The choice of alcohol addiction therapy depends on the current health condition of the patient and their issues. Increasing awareness regarding drawbacks of alcohol addiction across the globe is a major factor driving the growth of the target market. Furthermore, high import duties, high pricing, and imposing age limit are some of the measures adopted by governments in various countries to limit the consumption of alcohol is another factor supporting the target market growth.

A growing number of initiatives from government and public organizations by providing cost-free or low-cost treatment in some of the rehabilitation center is further driving the market growth. Many pharmaceutical companies have launched different drugs to control alcohol consumption, which inhibits the enzyme acetaldehyde dehydrogenase causing unpleasant reaction post alcohol consumption. The rising number of deaths owing to overconsumption and addiction of alcohol coupled with rising awareness regarding adverse effects of alcohol consumption is expected to augment the revenue growth of the alcohol addiction therapeutics market in the coming years.

Global Alcohol Addiction Therapeutics Market Revenue (US$ Mn), 2019–2029 

Global alcohol addiction therapeutics market is segmented on the basis of type, end user, and region. On the basis of type, the market is segmented into 5-HT3 receptor antagonist, antidotes, and others. The other segment accounts for the major revenue share and is expected to register highest growth over forecast period. On the basis of end user, the market is segmented into hospital pharmacies, retail pharmacies, rehabilitation centers, and others. The hospital pharmacies segment accounts for a major revenue share in the global alcohol addiction therapeutics market owing to the increasing number of rehabilitation centers or hospital to control the drug or alcohol abusers in developed and developing countries.

Global Alcohol Addiction Therapeutics Market Attractiveness Analysis by Type, 2013–2019

On the basis of region, the market is segmented into North America, Europe, APAC, South America and MEA. North America accounts for the major revenue share in the global alcohol addiction therapeutics market owing to increase higher incidences of alcohol abuse in the region, followed by APAC and Europe respectively. Regions such as South America and MEA are expected to register steady growth over the forecast period.

The research report on the global alcohol addiction therapeutics market includes profiles of some of major companies such as Cipla Limited, GlaxoSmithKline plc, Henry Schein, Inc., Merck & Co., Inc., Sun Pharmaceutical Industries, Inc., Mallinckrodt Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Mylan (Apicore US LLC), Noramco GmbH, Kinnov Therapeutics, Chronos Therapeutics Limited, Bionex Pharmaceuticals LLC, and Curemark LLC.

Key Market Segments

Type

• 5-Ht3 Receptor Antagonist
• Antidotes And Others

Application

• Hospital Pharmacies
• Retail Pharmacies
• Rehabilitation Centers And Others

Key Market Players included in the report:

• Cipla Limited
• GlaxoSmithKline plc
• Henry Schein Inc.
• Merck & Co. Inc.
• Sun Pharmaceutical Industries Inc.
• Mallinckrodt Pharmaceuticals
• Teva Pharmaceutical Industries Ltd.
• Mylan (Apicore US LLC)
• Noramco GmbH
• Kinnov Therapeutics
• Chronos Therapeutics Limited
• Bionex Pharmaceuticals LLC
• Curemark LLC

For the Alcohol Addiction Therapeutics Market research study, the following years have been considered to estimate the market size: